{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Fli-1", "apoptosis", "cancer progression", "inflammation", "traditional Chinese medicine drugs"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "28101351", "DateRevised": {"Year": "2020", "Month": "10", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "10", "Day": "24"}], "Language": ["eng"], "ELocationID": ["10.3892/mco.2016.1059"], "Journal": {"ISSN": "2049-9450", "JournalIssue": {"Volume": "5", "Issue": "6", "PubDate": {"Year": "2016", "Month": "Dec"}}, "Title": "Molecular and clinical oncology", "ISOAbbreviation": "Mol Clin Oncol"}, "ArticleTitle": "Pro-inflammatory effect of a traditional Chinese medicine formula with potent anti-cancer activity <i>in vitro</i> impedes tumor inhibitory potential <i>in vivo</i>.", "Pagination": {"StartPage": "717", "EndPage": "723", "MedlinePgn": "717-723"}, "Abstract": {"AbstractText": ["Medicinal formulas are a part of the complex discipline of traditional Chinese medicine that has been used for centuries in China and East Asia. These formulas predominantly consist of the extracts isolated from herbal plants, animal parts and medicinal minerals. The present study aimed to investigate the impact of 150 formulas, used as non-prescription drugs in China, on the treatment of cancer. A formula was identified, C54, commonly used to treat sore throats, which exhibited marked growth inhibition <i>in vitro</i>, associated with cell cycle arrest and apoptosis. Cytotoxicity was, in part, due to the ability of C54 to inhibit the expression and function of the transcription factor, Fli-1, leading to marked inhibition of leukemic cell growth in tissue culture. However, when injected into a model of leukemia initiated by Fli-1 activation, C54 only exhibited a limited tumor inhibition. C54 also did not suppress xenograft growth of the breast cancer cell line, MDA-MB-231, orthopedically transplanted into the mammary fat pad of severe combined immunodeficiency (SCID) mice. Notably, splenomegaly and accumulation of inflammatory CD11b<sup>+</sup>/Gr1<sup>+</sup> monocytes were observed in the tumors and spleens of C54-treated mice. As inflammation is known to accelerate tumor progression, this immune response may counteract the cell-autonomous effect of C54, and account for its limited tumor inhibitory effect <i>in vivo</i>. Combining C54 with an anti-inflammatory drug may improve the potency of C54 for treatment of certain cancers. The present study has highlighted the complexity of Chinese medicinal compounds and the need to thoroughly analyze their systemic effects at high concentrations <i>in vivo</i>."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou University, Guiyang, Guizhou 550025, P.R. China; Division of Biology and Chemistry, The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang, Guizhou 550008, P.R. China."}], "LastName": "Xia", "ForeName": "Lei", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Biology and Chemistry, The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang, Guizhou 550008, P.R. China."}], "LastName": "Plachynta", "ForeName": "Maksym", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Biology and Chemistry, The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang, Guizhou 550008, P.R. China."}], "LastName": "Liu", "ForeName": "Tangjingjun", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Biology and Chemistry, The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang, Guizhou 550008, P.R. China."}], "LastName": "Xiao", "ForeName": "Xiao", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Biology and Chemistry, The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang, Guizhou 550008, P.R. China."}], "LastName": "Song", "ForeName": "Jialei", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Biology and Chemistry, The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang, Guizhou 550008, P.R. China."}], "LastName": "Li", "ForeName": "Xiaogang", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Biology and Chemistry, The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang, Guizhou 550008, P.R. China."}], "LastName": "Zhang", "ForeName": "Mu", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Biology and Chemistry, The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang, Guizhou 550008, P.R. China."}], "LastName": "Yao", "ForeName": "Yao", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Biology and Chemistry, The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang, Guizhou 550008, P.R. China."}], "LastName": "Luo", "ForeName": "Heng", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Biology and Chemistry, The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang, Guizhou 550008, P.R. China; Department of Biological Sciences, Guiyang Medical University, Guiyang, Guizhou 550025, P.R. China."}], "LastName": "Hao", "ForeName": "Xiaojiang", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Biology and Chemistry, The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang, Guizhou 550008, P.R. China; Department of Biological Sciences, Guiyang Medical University, Guiyang, Guizhou 550025, P.R. China."}], "LastName": "Ben-David", "ForeName": "Yaacov", "Initials": "Y"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Mol Clin Oncol", "NlmUniqueID": "101613422", "ISSNLinking": "2049-9450"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Shaw D. Toxicological risks of Chinese herbs. Planta Med. 2010;76:2012\u20132018. doi: 10.1055/s-0030-1250533.", "ArticleIdList": ["10.1055/s-0030-1250533", "21077025"]}, {"Citation": "Wu XY, Tang JL, Mao C, Yuan JQ, Qin Y, Chung VC. Systematic reviews and meta-analyses of traditional chinese medicine must search chinese databases to reduce language bias. Evid Based Complement Alternat Med. 2013;2013:812179. doi: 10.1155/2013/812179.", "ArticleIdList": ["10.1155/2013/812179", "PMC3816048", "24223063"]}, {"Citation": "Leung AY. Traditional toxicity documentation of Chinese Materia Medica-an overview. Toxicol Pathol. 2006;34:319\u2013326. doi: 10.1080/01926230600773958.", "ArticleIdList": ["10.1080/01926230600773958", "16787890"]}, {"Citation": "Yang JX, Wang XM. Progress in studies on anti-hepatoma effect of traditional Chinese medicine by adjusting immune function. Zhongguo Zhong Yao Za Zhi. 2007;32:281\u2013284. (In Chinese)", "ArticleIdList": ["17455456"]}, {"Citation": "Yang D, Tian G. Review of experimental study on treatment of lung cancer with traditional Chinese medicine. Zhongguo Zhong Yao Za Zhi. 2009;34:2405\u20132409. (In Chinese)", "ArticleIdList": ["20030099"]}, {"Citation": "Li YJ, Zhao X, Vecchiarelli-Federico LM, Li Y, Datti A, Cheng Y, Ben-David Y. Drug-mediated inhibition of Fli-1 for the treatment of leukemia. Blood Cancer J. 2012;2:e54. doi: 10.1038/bcj.2011.52.", "ArticleIdList": ["10.1038/bcj.2011.52", "PMC3270256", "22829238"]}, {"Citation": "Li YJ, Liu G, Xia L, Xiao X, Liu JC, Menezes ME, Das SK, Emdad L, Sarkar D, Fisher PB, et al. Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic mice. Oncotarget. 2015;6:36943\u201336954.", "ArticleIdList": ["PMC4741907", "26460950"]}, {"Citation": "Usenko T, Li YJ, Haeri M, Li Y, Vecchiarelli-Federico LM, Zhao X, Prchal JT, Ben-David Y. Enrichment of Sca1+ hematopoietic progenitors in polycythemic mice inhibits leukemogenesis. Blood. 2009;114:1831\u20131841. doi: 10.1182/blood-2008-11-187419.", "ArticleIdList": ["10.1182/blood-2008-11-187419", "19584401"]}, {"Citation": "Livak KJ, Schmittgen TD. Analysis of Relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method. METHODS. 2001;25:402\u2013408. doi: 10.1006/meth.2001.1262.", "ArticleIdList": ["10.1006/meth.2001.1262", "11846609"]}, {"Citation": "Hermawan A, Wagner E, Roidl A. Consecutive salinomycin treatment reduces doxorubicin resistance of breast tumor cells by diminishing drug efflux pump expression and activity. Oncol Rep. 2016;35:1732\u20131740.", "ArticleIdList": ["26708059"]}, {"Citation": "Yu X, Yang L, Cairns MJ, Dass C, Saravolac E, Li X, Sun LQ. Chemosensitization of solid tumors by inhibition of Bcl-xL expression using DNAzyme. Oncotarget. 2014;5:9039\u20139048. doi: 10.18632/oncotarget.1996.", "ArticleIdList": ["10.18632/oncotarget.1996", "PMC4253417", "25344863"]}, {"Citation": "Lu SJ, Man S, Bani MR, Adachi D, Hawley RG, Kerbel RS, Ben-David Y. Retroviral insertional mutagenesis as a strategy for the identification of genes associated with cis-diamminedichloroplatinum(II) resistance. Cancer Res. 1995;55:1139\u20131145.", "ArticleIdList": ["7867000"]}, {"Citation": "Pastorek M, Gronesova P, Cholujova D, Hunakova L, Bujnakova Z, Balaz P, Duraj J, Lee TC, Sedlak J. Realgar (As4S4) nanoparticles and arsenic trioxide (As2O3) induced autophagy and apoptosis in human melanoma cells in vitro. Neoplasma. 2014;61:700\u2013709. doi: 10.4149/neo_2014_085.", "ArticleIdList": ["10.4149/neo_2014_085", "25150315"]}, {"Citation": "Chen J, Li L, Su J, Li B, Chen T, Wong YS. Synergistic apoptosis-inducing effects on A375 human melanoma cells of natural borneol and curcumin. PLoS One. 2014;9:e101277. doi: 10.1371/journal.pone.0101277.", "ArticleIdList": ["10.1371/journal.pone.0101277", "PMC4074168", "24971451"]}, {"Citation": "Lu Y, Chen X, Du S, Wu Q, Yao Z, Zhai Y. The in situ and in vivo study on enhancing effect of borneol in nasal absorption of Geniposide in rats. Arch Pharm Res. 2010;33:691\u2013696. doi: 10.1007/s12272-010-0507-8.", "ArticleIdList": ["10.1007/s12272-010-0507-8", "20512466"]}, {"Citation": "Li Y, Luo H, Liu T, Zacksenhaus E, Ben-David Y. The ets transcription factor Fli-1 in development, cancer and disease. Oncotarget. 2015;34:2022\u20132031.", "ArticleIdList": ["PMC5028196", "24909161"]}, {"Citation": "Ben-David Y, Giddens EB, Letwin K, Bernstein A. Erythroleukemia induction by Friend murine leukemia virus: Insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 1991;5:908\u2013918. doi: 10.1101/gad.5.6.908.", "ArticleIdList": ["10.1101/gad.5.6.908", "2044959"]}, {"Citation": "Lee CR, Cervi D, Truong AH, Li YJ, Sarkar A, Ben-David Y. Friend virus-induced erythroleukemias: A unique and well-defined mouse model for the development of leukemia. Anticancer Res. 2003;23:2159\u20132166.", "ArticleIdList": ["12894591"]}, {"Citation": "Athanasiou M, Mavrothalassitis G, Sun-Hoffman L, Blair DG. FLI-1 is a suppressor of erythroid differentiation in human hematopoietic cells. Leukemia. 2000;14:439\u2013445. doi: 10.1038/sj.leu.2401689.", "ArticleIdList": ["10.1038/sj.leu.2401689", "10720139"]}, {"Citation": "Zochodne B, Truong AH, Stetler K, Higgins RR, Howard J, Dumont D, Berger SA, Ben-David Y. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: Implication for erythropoiesis and Friend virus-induced erythroleukemia. Oncogene. 2000;19:2296\u20132304. doi: 10.1038/sj.onc.1203590.", "ArticleIdList": ["10.1038/sj.onc.1203590", "10822380"]}, {"Citation": "Lakhanpal GK, Vecchiarelli-Federico LM, Li YJ, Cui JW, Bailey ML, Spaner DE, Dumont DJ, Barber DL, Ben-David Y. The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis. Blood. 2010;116:428\u2013436. doi: 10.1182/blood-2009-10-250217.", "ArticleIdList": ["10.1182/blood-2009-10-250217", "20445019"]}, {"Citation": "Ben-David Y, Giddens EB, Bernstein A. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. Proc Natl Acad Sci USA. 1990;87:1332\u20131336. doi: 10.1073/pnas.87.4.1332.", "ArticleIdList": ["10.1073/pnas.87.4.1332", "PMC53469", "2304901"]}, {"Citation": "Emi M, Kim R, Tanabe K, Uchida Y, Toge T. Targeted therapy against Bcl-2-related proteins in breast cancer cells. Breast Cancer Res. 2005;7:R940\u2013952. doi: 10.1186/bcr1323.", "ArticleIdList": ["10.1186/bcr1323", "PMC1410745", "16280040"]}, {"Citation": "Nold MF, Mangan NE, Rudloff I, Cho SX, Shariatian N, Samarasinghe TD, Skuza EM, Pedersen J, Veldman A, Berger PJ, Nold-Petry CA. Interleukin-1 receptor antagonist prevents murine bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia. Proc Natl Acad Sci USA. 2013;110:14384\u201314389. doi: 10.1073/pnas.1306859110.", "ArticleIdList": ["10.1073/pnas.1306859110", "PMC3761642", "23946428"]}, {"Citation": "Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9:162\u2013174. doi: 10.1038/nri2506.", "ArticleIdList": ["10.1038/nri2506", "PMC2828349", "19197294"]}, {"Citation": "Meyer C, Sevko A, Ramacher M, Bazhin AV, Falk CS, Osen W, Borrello I, Kato M, Schadendorf D, Baniyash M, Umansky V. Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model. Proc Natl Acad Sci USA. 2011;108:17111\u201317116. doi: 10.1073/pnas.1108121108.", "ArticleIdList": ["10.1073/pnas.1108121108", "PMC3193202", "21969559"]}, {"Citation": "Zhang F, Lu Y, Liu J, Shi J. Realgar is active ingredient of Angong Niuhuang pill in protection against LPS-induced neuroinflammation. Zhongguo Zhong Yao Za Zhi. 2010;35:3333\u20133338. (In Chinese)", "ArticleIdList": ["21438402"]}, {"Citation": "Zhang F, Lu Y, Wu Q, Yan J, Shi J, Liu J. Role of cinnabar and realgar of WSHFD in protecting against LPS-induced neurotoxicity. J Ethnopharmacol. 2012;139:822\u2013828. doi: 10.1016/j.jep.2011.12.026.", "ArticleIdList": ["10.1016/j.jep.2011.12.026", "22207210"]}, {"Citation": "Zhong W, Cui Y, Yu Q, Xie X, Liu Y, Wei M, Ci X, Peng L. Modulation of LPS-stimulated pulmonary inflammation by Borneol in murine acute lung injury model. Inflammation. 2014;37:1148\u20131157. doi: 10.1007/s10753-014-9839-8.", "ArticleIdList": ["10.1007/s10753-014-9839-8", "24566873"]}, {"Citation": "Cui JW, Vecchiarelli-Federico LM, Li YJ, Wang GJ, Ben-David Y. Continuous Fli-1 expression plays an essential role in the proliferation and survival of F-MuLV-induced erythroleukemia and human erythroleukemia. Leukemia. 2009;23:1311\u20131319. doi: 10.1038/leu.2009.20.", "ArticleIdList": ["10.1038/leu.2009.20", "19282832"]}, {"Citation": "Cervi D, Klement G, Stempak D, Baruchel S, Koki A, Ben-David Y. Targeting cyclooxygenase-2 reduces overt toxicity toward low-dose vinblastine and extends survival of juvenile mice with Friend disease. Clin Cancer Res. 2005;11:712\u2013719.", "ArticleIdList": ["15701860"]}, {"Citation": "Motallebnezhad M, Jadidi-Niaragh F, Qamsari ES, Bagheri S, Gharibi T, Yousefi M. The immunobiology of myeloid-derived suppressor cells in cancer. Tumour Biol. 2016;37:1387\u20131406. doi: 10.1007/s13277-015-4477-9.", "ArticleIdList": ["10.1007/s13277-015-4477-9", "26611648"]}, {"Citation": "Parker KH, Beury DW, Ostrand-Rosenberg S. Myeloid-derived suppressor cells: Critical cells driving immune suppression in the tumor microenvironment. Adv Cancer Res. 2015;128:95\u2013139. doi: 10.1016/bs.acr.2015.04.002.", "ArticleIdList": ["10.1016/bs.acr.2015.04.002", "PMC4662416", "26216631"]}]}], "History": [{"Year": "2016", "Month": "5", "Day": "5"}, {"Year": "2016", "Month": "9", "Day": "9"}, {"Year": "2017", "Month": "1", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "20", "Hour": "6", "Minute": "1"}, {"Year": "2016", "Month": "10", "Day": "24"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28101351", "PMC5228291", "10.3892/mco.2016.1059", "MCO-0-0-1059"]}}]}